LFMD
LifeMD, Inc.3.4200
+0.1500+4.59%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
164.62MP/E (TTM)
-Basic EPS (TTM)
-0.25Dividend Yield
0%Recent Filings
10-K
FY2025 results
LifeMD drove FY2025 telehealth revenue to $194.1M, up 25% y/y from $154.8M in 2024, fueled by subscription growth across primary care and weight management, with ~95% recurring. Gross margins held steady at 86% despite 29% higher costs from volume; operating loss narrowed to $7.7M from $20.4M as marketing ramped efficiently. Q4 momentum shone through WorkSimpli divestiture, netting $21.3M gain from discontinued ops, and OHHMD acquisition bolstering women's health. Cash at $36.8M funds growth; debt cleared. Material weaknesses persist in controls. GLP-1 compounding risks loom large.
8-K
LifeMD Q4 revenue $46.9M
LifeMD reported Q4 2025 revenue up 4% to $46.9M with adjusted EBITDA surging 348% to $4.8M; full-year revenue climbed 25% to $194.1M, adjusted EBITDA 309% to $15.3M. Debt-free with $36.8M cash, it launched oral Wegovy post-year-end amid record Q1 sign-ups. Q1 2026 guides $48-49M revenue but EBITDA loss from GLP-1 investments. Run-rate revenue tops $250M by year-end.
8-K
LifeMD closes $30M revolver
LifeMD inked a $30M senior secured revolver with Citizens Bank on January 2, 2026, maturing January 2, 2029, expandable by $20M. No draws yet; funds earmarked for corporate development or shareholder value plays. Yet covenants kick in Q1 2026: leverage ≤2.5x, interest coverage ≥3.0x. Flexibility secured.
8-K
Q3 revenue up 13%
10-Q
Q3 FY2025 results
LifeMD posted Q3 revenue of $60.2M, up 13% y/y from $53.3M, with telehealth jumping 18% y/y to $47.3M on LifeMD primary care demand while WorkSimpli dipped 2% y/y to $12.9M. Gross profit hit $52.8M (88% margin), off from 91% y/y as telehealth costs rose to 14% on physician fees and shipping, yet operating loss narrowed to $2.0M from $4.0M y/y. Operating cash flow YTD stands at $11.6M; cash ended at $23.8M after extinguishing all debt. Debt gone. Sold WorkSimpli post-quarter. Material weaknesses persist in revenue controls.
IPO
Website
Employees
Sector
Industry
DOCS
Doximity, Inc.
43.80-0.85
DRIO
DarioHealth Corp.
12.05+0.05
HIMS
Hims & Hers Health, Inc.
36.86+0.61
HYDTF
Hydreight Technologies Inc
3.10-0.06
LVCE
LIVECARE INC
0.01+0.00
MGRX
Mangoceuticals, Inc.
1.20+0.06
MNDR
Mobile-health Network Solutions
1.08+0.02
OMDA
Omada Health, Inc.
14.61+0.02
TALK
Talkspace, Inc.
3.55+0.04
TDOC
Teladoc Health, Inc.
7.41+0.07